Market leading sales of fluorescence spectrometers for multidisciplinary applications
Submitting Institution
University of StrathclydeUnit of Assessment
PhysicsSummary Impact Type
TechnologicalResearch Subject Area(s)
Physical Sciences: Atomic, Molecular, Nuclear, Particle and Plasma Physics, Other Physical Sciences
Biological Sciences: Biochemistry and Cell Biology
Summary of the impact
    Fluorescence lifetime research since 1993 in Strathclyde's Photophysics
      Group led by Prof. David Birch contributed to the success of the
      University spin-out company IBH (Imhof, Birch, Hallam), and its successful
      merger with the £1Bn multinational company Horiba. The Strathclyde
      research has helped Horiba to be, since 2008, the market-leading supplier
      of fluorescence spectrometers, which comprise steady-state, lifetime and
      hybrid instruments. The commercial success of the company has led to
      economic benefits and employment. Through production of an improved
      spectrometry product range, the Strathclyde research has also facilitated
      multidisciplinary molecular and materials research globally, across
      Industry, Government and University sectors, bringing benefits to diverse
      disciplines such as life sciences, healthcare, chemistry, and
      nanotechnology.
    Underpinning research
    Context
    Fluorescence is the emission of light by a molecule when excited with
      light. The fluorescence spectrum and excited state lifetime (typically
      nanosecond) are fingerprints of the emitting molecule and its local
      environment. The properties of fluorescence, including quantum yield,
      single molecule sensitivity, and polarization, and implementation in
      tracking molecular kinetics, imaging and microscopy, have served to
      establish fluorescence globally as a primary analytical technique.
      Sequencing the human genome and immunoassay for disease diagnostics are
      two well-known applications. Indeed, fluorescence has particular
      importance in medical research and the life sciences, disciplines that
      require routine operation of equipment by users who are not usually
      instrumentation specialists. This case study is based on research that
      improved performance in the main growth area of fluorescence spectroscopy,
      namely excited state lifetime studies, which opened up new application
      opportunities and led to considerable commercial success.
    Key findings
    Research published in the period 1996 - 2004 resulted in a number of
      important discoveries and innovations as indicated below [numbers refer to
      the references in section 3].
    [1] An inexpensive, miniaturized and portable blue-green InGaN
      light-emitting diode (LED) source and drive electronics for obtaining
      pulses of ~ 1.9 ns at up to 10 MHz repetition rate. It was shown to be
      ideal for faster acquisition of fluorescence decay data using the most
      popular method of time-correlated single-photon counting (TCSPC).
      Previously LEDs operated only at ~10 kHz. Fluorescence and rotational
      decay times of the dye rhodamine 6G agreed with previous values obtained
      with a Ti:Sapphire laser at ~100x the cost. The approach opened up new
      markets involving molecules/samples that changed rapidly e.g. silica
      nanoparticle growth [5], and sensing e.g. glucose for diabetes [6].
    [2]. This joint paper with IBH describes a disruptive new LED technology
      that enabled for the first time the routine and inexpensive excitation of
      protein intrinsic fluorescence decay using a semiconductor source. Until
      this work the alternatives were expensive mode-locked lasers or unreliable
      and unstable spark lamps, which limited applications. The paper reported
      excitation of the amino acid tyrosine at 280 nm. Subsequent joint
      publications with IBH addressed the fluorescent amino acids tryptophan and
      phenylalanine, and protein. The technology propelled the IBH NanoLED
      global market [text removed for publication]. Dr David McLoskey led the
      IBH contribution.
    [3]. The capability of fluorescence lifetime measurement was enhanced
      when the Photophysics Group were the first to demonstrate in this work
      multi-photon excitation (MPE) combined with TCSPC data acquisition. The
      different selection rules for MPE can provide extra selectivity, but this
      paper demonstrated an increased dynamic range of anisotropy decay, aiding
      precision in particle metrology [5]. MPE-TCSPC is now widely used in
      fluorescence lifetime imaging (FLIM).
    [4]. This paper developed our patented invention of multiplexed TCSPC in
      the first application specific integrated circuit (ASIC) designed for
      fluorescence lifetime. The ASIC enabled 16 channels of fluorescence data
      e.g. decay vs. wavelength, position etc., to be recorded simultaneously.
      The paper shows some of the first TCSPC lifetime images, thus helping to
      pave the way to fluorescence lifetime imaging , which is now used
      universally e.g. in the Horiba DynaMyc. Prof. P Hicks of UMIST led the
      ASIC design.
    [5]. There is a global environmental and healthcare requirement for
      better alternatives to expensive scattering techniques and electron
      microscopy for measuring nanoparticle size in the critical 1-10 nm range
      that easily traverses cellular membranes. This paper showed the accepted
      model of the bi-exponential fluorescence polarization anisotropy decay
      observed during the gelling of silica sols, and based on the co-existence
      of dual viscosities, was in fact incorrect and proposed a new model in
      terms of Brownian rotation of free dye and dye bound to nanoparticles.
      This led to a new method for nanoparticle metrology in-situ. The work was
      in collaboration with Unilever.
    [6]. The ongoing collaboration, since 1997, with Kings College London
      School of Medicine/Guys Hospital on in-vivo glucose sensing for diabetes
      management using fluorescence, demonstrated the usefulness of TCSPC in the
      quest for a non-invasive sensor. Prior to this work frequency domain
      lifetime measurement had been the main approach. The paper also described
      an improvement in a sensor for serum glucose based on Concanvalin A by
      compatibility with the therapeutic window in skin. Prof. John Pickup led
      the medical part at KCL.
    Key researchers at Strathclyde
    Prof. D Birch academic in Department of Physics from 1/09/78 to present,
    Dr O Rolinski. Senior Lecturer in Department of Physics from14/04/94 to
      present.
    Prof. D Sherrington academic in Pure and Applied Chemistry 1/09/71 to
      29/02/12 now retired.
    References to the research
    Outputs 2, 5 and 6 best represent the quality of the underpinning
        research.
    
[1] MHz LED source for nanosecond fluorescence sensing. W J
      O'Hagan, M McKenna, D C Sherrington, O J Rolinski, & D J S Birch.
      Meas. Sci. Technol. 13, 84-91, 2002.
     
[2] A new sub-nanosecond LED at 280 nm: application to protein
        fluorescence. C D McGuiness, K Sagoo, D McLoskey & D J S Birch.
      Meas. Sci. Technol. 15, L19-22, 2004.
     
[3] Time-resolved non-linear fluorescence spectroscopy using
        femtosecond multi-photon excitation and single-photon timing detection.
      A Volkmer, D A Hatrick & D J S Birch, Meas. Sci. Technol. 8, 1339-49,
      1997.
     
[4] Multiplexed single-photon counting 1: A time-correlated
        fluorescence lifetime camera. D McLoskey, D J S Birch, A Sanderson,
      K Suhling, E Welch & P J Hicks, Rev. Sci. Instrum. 67, 2228-37, 1996.
     
[5] Sol-gel particle growth studied using fluorescence anisotropy: An
        alternative to scattering techniques. D J S Birch & C D Geddes.
      Phys. Rev. E. 62, 2977-80, 2000.
     
[6] Near-infrared fluorescence lifetime assay for serum glucose based
        on allophycocyanin-labeled concanavlin A. L J McCartney, J C Pickup,
      O J Rolinski & D J S Birch. Anal. Biochem. 292, 216-21, 2001.
     
Other evidence for quality of research
    (Numbers refer to the references above).
    [1]. Supported by a £128k EPSRC Award "Fluorescence lifetime sensors for
      metal ions" during 1998-2001. Overall assessment: "Tending to
      outstanding."
    [2]. The UV-LED source described received global scientific press
      coverage e.g. Biophotonics International and Chemistry World.
    [3]. Chosen as 1 of best 5 papers in Meas.Sci.Technol. in 1997. Led to a
      £150k GSK award in 2002.
    [4]. The Birch-Imhof invention of a 2 channel version was patented by the
      University of Strathclyde (International Patent WO 85/03352) and in
      1990-93 EPSRC funded a 3 channel version "Optical fibre fluorometry" with
      £108k. Overall assessment: "Very significant contribution to the field."
    [5]. Our technique has been used by many other research groups [text
      removed for publication]. The work formed part of the1997-9 £198k EPSRC
      Award "Fluorescence dynamics in confined water: application to the
      structure of silica hydrogels." Scientific/technological assessment: "Very
      significant contribution to the field." Follow-on funding was through the
      2000-3 £240k EPSRC Award "Nanometre silica particle metrology in sol-gels
      using fluorescence anisotropy." Overall assessment: "Outstanding."
    [6]. The collaboration with KCL was highlighted as 1 of 5 excellent
      research outcomes in the 2011 EPSRC review of Science & Innovation
      Awards (SIA). Press coverage included EPSRC Impact Case Study 36.
      Collaborations with KCL led by David Birch, include the £5m SIA in
      nanometrology and the £500k EPSRC Adventure Fund proposal "Single molecule
      sensing in clinical medicine," [text removed for publication] (overall
      final assessment: "Tending to Outstanding").
    Details of the impact
    Process/events from research to impact
    IBH was incorporated in 1977 and its acquisition by Horiba in 2003 to
      form Horiba Jobin Yvon IBH Ltd brought together IBH-Strathclyde's leading
      technology in pulsed fluorescence lifetime systems, with Horiba's
      steady-state (SS) fluorescence systems to produce a joint product line
      (Source 1) that paved the way to market supremacy. David Birch co-founded
      IBH and the Photophysics Group in 1977/8, served as IBH Chairman 1977-2003
      and is presently Horiba Jobin Yvon IBH Director of Science and Technology.
      His role, bridging between research, new products and the market, has been
      crucial to achieving commercial success. The process to impact started by
      demonstrating new instrument capabilities and applications through
      publications, which developed the field, attracted the market to related
      instrument products, and built the brand and reputation of IBH and Horiba.
    Description of impact
    Since 2008, Horiba and IBH together have won the largest market share of
      fluorescence spectrometer sales. From this flows a sustainable business,
      investment for innovation, and an extensive global customer base pursuing
      diverse applications.
    Improved products: The fluorescence spectrometer market is
      comprised primarily of three parts. Fluorescence spectrometers,
      incorporating steady-state (SS) sources, stand-alone fluorescence lifetime
      spectrometers incorporating pulsed sources, and hybrid spectrometers that
      combine both spectra and lifetime capabilities. Following the IBH-Horiba
      merger, market impact was realized by upgrading Horiba's global SS
      spectrometer user base with IBH's lifetime capability and the sale of new
      instruments. [text removed for publication] Specifically, the present
      IBH-Horiba lifetime-SS spectrometer range offers a more complete
      measurement solution for non-specialist users than was hitherto available
      from any supplier, as evidenced by the market leading position. The
      seminal breakthrough was the transition from ~ 30 kHz pulsed spark lamp
      sources to the more reliable and higher repetition rate semiconductor
      sources (References 1 and 2). This launched a new range of spectrometers
      based on the laser diodes and LEDs of the 1 MHz NanoLED and 100 MHz Delta
      product ranges. These offered higher time resolution, stability, data
      acquisition rate and ease of use, all at a reduced price (down to <
      $30k). This enabled expansion into key research markets in life-sciences,
      medicine and bionanotechnology. In his definitive book "Principles of
      Fluorescence Spectroscopy" 3rd ed., Springer 2006, JR Lakowicz wrote about
      papers 1 and 2 "Perhaps the most important development for TCSPC since
        2000 is the introduction of pulsed-laser diodes and pulsed
        light-emitting diodes......While this chapter was being written, the
        first report appeared on excitation of intrinsic protein fluorescence
        using a pulsed LED." This research was crucial to the instrument
      developments that had such a significant market impact from 2008.
    Market leading sales: The combined global market for fluorescence
      SS and lifetime spectrometers exceeds £100M. It has been reported, "Horiba
        has a solid lead in the market due in part to its wide range of popular
        lifetime fluorescence instruments, which is a segment of the market in
        which it dominates" (Source 3). Sales of the joint product line of
      IBH's fluorescence lifetime technology and Horiba's SS systems grew by
      [text removed for publication] from 2008-2012 to secure, since 2008, the
      largest global market share of 15% [text removed for publication]. This is
      significantly higher than that of other well-known brands e.g. PerkinElmer
      (11%), Thermo-Scientific (10%), Shimadzu (9%) and Hitachi (9%). The data
      is from market analysts Strategic Directions Inc. who highlight in Sources
      2 and 3Horiba's dominance due to IBH's fluorescence lifetime technology.
    Global adoption of technology across research laboratories:
      Adoption of the Strathclyde research in the fluorescence spectrometer
      products has benefited customers and their research outcomes across the
      globe, serving diverse disciplines such as life sciences, healthcare,
      chemistry, and materials. Sequencing the human genome and immunoassay for
      disease diagnostics are two important areas the products have supported.
      Research into improved healthcare is over 50% of the market and grand
      challenges addressed include diabetes, neurodegeneration and cancer. An
      expert in fluorescence at Brown University (Source 4) wrote "Without
        your research and your successful commercial exploitation there is no
        doubt fluorescence lifetime would not be the major technique it is
        today" and expert in fluorescence at Texas Christian University
      (TCU) wrote "The instrument systems you have helped design and
        develop, and that have been manufactured by the company you started,
        Horiba Jobin Yvon IBH Ltd in Glasgow, are used by leading laboratories
        all over the world" (Source 5).
    Skilled employment: The IBH market-leading position helps generate
      and sustain employment. [text removed for publication] Its business model
      makes significant use of UK sub-contractors and a highly skilled staff.
      The success of IBH contributed directly to the start-up, by former IBH
      Director Dr Anthony Hallam, of Sim4t Ltd. in 2012, an educational software
      and research training company, with its first products based on the
      simulation of TCSPC fluorescence lifetime decay data.
    Training: The impact of the research has been fostered by global
      dissemination activities such as the FluoroFest workshop series (Source 6)
      initiated by David Birch, sponsored by Horiba and launched in Prague in
      2009, with subsequent events in California (2010,2011) Munich (2011),
      Maryland (2012), Kyoto (2012) and Texas (May 2013). An expert in
      fluorescence at Brown University comments in his letter to David Birch "Finally,
        let me mention the great job you have done in disseminating research in
        fluorescence through your initiation of the globally acclaimed
        FluoroFest hands-on international workshop series. I have personally
        attended ... these events and they are to the benefit of the whole
        fluorescence community" (Source 4). In collaboration with Sim4t, the
      CPD course "Fluorescent nanoparticles and molecules for nanomedicine", was
      trialled at the Czech Technical University in 2013 (Source 7).
    Sources to corroborate the impact 
    
      - Products described at: http://www.horiba.com/scientific/products/fluorescence-spectroscopy/
 
      - Independent analysis in Strategic Directions International Inc. Global
        Assessment Report 11th Edition and Market forecast 2009-14.
        The Laboratory Analytical & Life Science Instrumentation Industry.
        Oct.2010. Page 245
 
      - Strategic Directions International Inc. Global Assessment Report 12th
        Edition and Market forecast 2012-16. The Laboratory Analytical &
        Life Science Instrumentation Industry. Oct.2012. Page 265
 
        Note: Taken together 2 and 3 show that Horiba's overall market lead in
        the combined fluorescence steady-state and lifetime based systems is due
        to the fluorescence lifetime products produced by IBH, these in turn
        being underpinned by the Strathclyde research.
      - Statement from US expert in fluorescence Brown University
 
      - Statement from US expert in fluorescence Texas Christian University.
 
      - International training workshops at:www.fluorofest.org/
        (past workshops tab)
 
      - International training workshop http://box.fbmi.cvut.cz/index.php/en/